Value of functional in-vivo endpoints in preclinical radiation research

CONCLUSIONS: GD/Gy with at least two dose groups correlates with TCD50, but cannot replace the latter as the goldstandard.PMID:33639191 | DOI:10.1016/j.radonc.2021.02.024

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - February 27, 2021 Category: Radiology Authors: Berit Kummer Steffen L öck Kristin Gurtner Nadine Hermann Ala Yaromina Wolfgang Eicheler Michael Baumann Mechthild Krause Christina Jentsch Source Type: research